This company listing is no longer active
Immunovia Past Earnings Performance
Past criteria checks 0/6
Immunovia's earnings have been declining at an average annual rate of -19.9%, while the Medical Equipment industry saw earnings growing at 14.4% annually. Revenues have been declining at an average rate of 50.4% per year.
Key information
-19.9%
Earnings growth rate
-14.5%
EPS growth rate
| Medical Equipment Industry Growth | 6.2% |
| Revenue growth rate | -50.4% |
| Return on equity | -68.9% |
| Net Margin | -14,680.5% |
| Next Earnings Update | 23 May 2023 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Immunovia makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 22 | 1 | -168 | 163 | 0 |
| 30 Sep 22 | 1 | -148 | 162 | 0 |
| 30 Jun 22 | 1 | -161 | 158 | 0 |
| 31 Mar 22 | 1 | -177 | 165 | 0 |
| 31 Dec 21 | 1 | -156 | 162 | 0 |
| 30 Sep 21 | 1 | -155 | 165 | 0 |
| 30 Jun 21 | 0 | -157 | 175 | 0 |
| 31 Mar 21 | 0 | -142 | 161 | 0 |
| 31 Dec 20 | 0 | -146 | 165 | 0 |
| 30 Sep 20 | 0 | -133 | 213 | 0 |
| 30 Jun 20 | 0 | -120 | 184 | 0 |
| 31 Mar 20 | 0 | -116 | 162 | 0 |
| 31 Dec 19 | 0 | -115 | 133 | 0 |
| 30 Sep 19 | -19 | -108 | 52 | 0 |
| 30 Jun 19 | -13 | -99 | 51 | 0 |
| 31 Mar 19 | -6 | -96 | 48 | 0 |
| 31 Dec 18 | 0 | -87 | 45 | 0 |
| 30 Sep 18 | 29 | -76 | 46 | 0 |
| 30 Jun 18 | 26 | -70 | 38 | 0 |
| 31 Mar 18 | 25 | -55 | 34 | 0 |
| 31 Dec 17 | 24 | -45 | 31 | 0 |
| 30 Sep 17 | 23 | -35 | 24 | 0 |
| 30 Jun 17 | 24 | -28 | 23 | 0 |
| 31 Mar 17 | 25 | -20 | 19 | 0 |
| 31 Dec 16 | 24 | -15 | 16 | 0 |
| 30 Sep 16 | 22 | -11 | 12 | 0 |
| 30 Jun 16 | 22 | -9 | 11 | 0 |
Quality Earnings: IMMNOV BTA is currently unprofitable.
Growing Profit Margin: IMMNOV BTA is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: IMMNOV BTA is unprofitable, and losses have increased over the past 5 years at a rate of 19.9% per year.
Accelerating Growth: Unable to compare IMMNOV BTA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: IMMNOV BTA is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-11.1%).
Return on Equity
High ROE: IMMNOV BTA has a negative Return on Equity (-68.95%), as it is currently unprofitable.